Neoplasms Metastasis Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02376699Safety Study of SEA-CD40 in Cancer PatientsTreatment
NCT03138889A Study of a CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 (Pembrolizumab) and of NKTR-214 in Combination With Anti-PD-L1 (Atezolizumab) in Patients With Select Advanced or Metastatic Solid TumorsTreatment